| |
| |
|
| Insider
Information: |
Klausner Richard |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,990,681 |
|
|
Indirect Shares
|
930,880 |
|
|
| Direct
Value |
$9,251,523 |
|
|
|
Indirect Value
|
$2,020,010 |
|
|
| Total
Shares |
3,921,561 |
|
|
| Total
Value |
$11,271,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -43.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Illumina Inc |
ILMN |
Sr VP, Chief Medical O... |
2016-01-29 |
22,847 |
|
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-03-05 |
0 |
|
0 |
Premium* |
|
|
Lyell Immunopharma, Inc. |
LYEL |
Director |
2023-08-15 |
2,967,834 |
2023-08-15 |
930,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2023-08-15 |
4 |
S |
$2.28 |
$132,286 |
I/I |
(58,020) |
930,880 |
0 |
% |
|
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2022-09-23 |
4 |
S |
$6.40 |
$71,041 |
I/I |
(11,100) |
988,900 |
0 |
% |
|
| LYEL |
Lyell Immunopharma, Inc. |
Executive Chairman |
• • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,765,842 |
3,765,842 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
D |
$87.00 |
$61,380,675 |
D/D |
(705,525) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,250 |
705,525 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-01-08 |
4 |
AS |
$46.85 |
$613,392 |
D/D |
(12,724) |
728,775 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
741,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-12-21 |
4 |
AS |
$44.72 |
$1,611,356 |
D/D |
(36,000) |
741,251 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
266 |
777,251 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-09-07 |
4 |
AS |
$42.27 |
$511,865 |
D/D |
(12,000) |
776,985 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-08-07 |
4 |
AS |
$30.34 |
$364,091 |
D/D |
(12,000) |
788,985 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-07-07 |
4 |
AS |
$29.38 |
$705,320 |
D/D |
(24,000) |
800,985 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
380 |
824,985 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-06-07 |
4 |
AS |
$23.23 |
$566,362 |
D/D |
(24,000) |
824,605 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
514 |
848,605 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
591 |
848,091 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
401 |
847,500 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
847,099 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-06-24 |
4 |
AS |
$40.71 |
$488,496 |
D/D |
(12,000) |
846,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-05-18 |
4 |
AS |
$40.00 |
$480,000 |
D/D |
(12,000) |
858,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-15 |
4 |
AS |
$42.79 |
$514,857 |
D/D |
(12,000) |
870,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
882,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-03-22 |
4 |
AS |
$40.00 |
$480,000 |
D/D |
(12,000) |
882,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-03-02 |
4 |
AS |
$40.39 |
$970,023 |
D/D |
(24,000) |
894,499 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2016-01-29 |
4 |
D |
$157.95 |
$39,961 |
D/D |
(253) |
22,847 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
